Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
BioLife Solutions
BLFS
$1.53B
| $630K | ﹤0.01% |
17,520
+12,981
| +286% | +$513K |
|
3027
Santander
BSBR
$42.5B
| $627K | ﹤0.01% |
92,763
+87,226
| +1,575% | +$621K |
|
3028
Covenant Logistics
CVLG
$894M
| $627K | ﹤0.01% |
60,910
-4,532
| -7% | -$40.5K |
|
3029
CALL
Dow Inc
DOW
$21.9B
| $627K | ﹤0.01% |
9,800
-32,126
| -77% | -$1.92M |
|
3030
Puma Biotechnology
PBYI
$404M
| $625K | ﹤0.01% |
64,349
-14,583
| -18% | -$163K |
|
3031
Metallus
MTUS
$838M
| $625K | ﹤0.01% |
53,208
-26,412
| -33% | -$197K |
|
|
FBMS
3032
DELISTED
The First Bancshares, Inc.
FBMS
| $625K | ﹤0.01% |
17,057
+10,383
| +156% | +$349K |
|
|
XIFR
3033
XPLR Infrastructure LP
XIFR
$1.12B
| $623K | ﹤0.01% |
8,538
-5,414
| -39% | -$416K |
|
3034
Ecovyst
ECVT
$1.32B
| $621K | ﹤0.01% |
37,218
-14,245
| -28% | -$226K |
|
3035
PUT
Bath & Body Works
BBWI
$4.06B
| $619K | ﹤0.01% |
12,370
-380,254
| -97% | -$15.7M |
|
3036
Liquidity Services
LQDT
$1.22B
| $617K | ﹤0.01% |
33,138
+3,576
| +12% | +$64.7K |
|
|
BFX
3037
DELISTED
BowFlex Inc.
BFX
| $615K | ﹤0.01% |
39,339
+2,633
| +7% | +$56.6K |
|
|
SRG
3038
Seritage Growth Properties
SRG
$136M
| $614K | ﹤0.01% |
33,463
-120,363
| -78% | -$2.23M |
|
|
ETRN
3039
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $613K | ﹤0.01% |
75,012
+33,912
| +83% | +$258K |
|
3040
Aterian
ATER
$4.45M
| $612K | ﹤0.01% |
1,729
+1,021
| +144% | +$393K |
|
|
BCYC
3041
Bicycle Therapeutics
BCYC
$269M
| $612K | ﹤0.01% |
+20,500
| New | +$529K |
|
3042
Marcus Corp
MCS
$897M
| $609K | ﹤0.01% |
30,464
-150,362
| -83% | -$2.78M |
|
3043
CALL
Procter & Gamble
PG
$336B
| $609K | ﹤0.01% |
4,500
-168,300
| -97% | -$22M |
|
|
PFBI
3044
DELISTED
Premier Financial Bancorp
PFBI
| $607K | ﹤0.01% |
32,669
+15,780
| +93% | +$253K |
|
3045
Aldeyra Therapeutics
ALDX
$92.9M
| $603K | ﹤0.01% |
+50,745
| New | +$584K |
|
3046
ANI Pharmaceuticals
ANIP
$1.8B
| $601K | ﹤0.01% |
16,616
+1,230
| +8% | +$38.5K |
|
3047
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.52B
| $601K | ﹤0.01% |
+4,171
| New | +$600K |
|
3048
Silgan Holdings
SLGN
$4.23B
| $601K | ﹤0.01% |
14,305
+8,495
| +146% | +$332K |
|
3049
CALL
MGM Resorts International
MGM
$11.4B
| $600K | ﹤0.01% |
15,800
-295,400
| -95% | -$10.3M |
|
3050
HCI Group
HCI
$2.23B
| $599K | ﹤0.01% |
7,785
-4,829
| -38% | -$304K |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.